Effects of Losartan, Tempol, and Their Combination On Renal Nitric Oxide Synthases in the Animal Model of Chronic Kidney Disease
Down-regulation of nitric oxide synthase (NOS) and NO deficiency in the kidneys have been implicated in the pathogenesis of chronic kidney disease (CKD). In this study we examined the effects of losartan, tempol, and combined treatment on three NOS isoforms expressions, kidney NO content and NOS cor...
Guardado en:
Autores principales: | Karanovic Danijela, Grujic-Milanovic Jelica, Miloradovic Zoran, Ivanov Milan, Jovovic Djurdjica, Vajic Una-Jovana, Cirovic Sanja, Markovic-Lipkovski Jasmina, Mihailovic-Stanojevic Nevena |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0330bb131344c36a370aa8446703eb8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined Angiotensin II Type-1 Receptor Blockade and Superoxide Anion Scavenging Affect the Post-Ischemic Kidney in Hypertensive Rats
por: Ivanov Milan, et al.
Publicado: (2016) -
In Vivo Investigation of the Ameliorating Effect of Tempol against MIA-Induced Knee Osteoarthritis in Rats: Involvement of TGF-β1/SMAD3/NOX4 Cue
por: Hagar B. Abo-zalam, et al.
Publicado: (2021) -
IN VITRO EVIDENCES FOR SIMVASTATIN AND LOSARTAN POTASSIUM INTERACTION AND ITS IN VIVO IMPLICATIONS
por: SAEED ARAYNE,M, et al.
Publicado: (2009) -
Managing blood pressure control in Asian patients: safety and efficacy of losartan
por: Cheung TT, et al.
Publicado: (2014) -
Cálculo del impacto económico para Chile del uso de losartán en diabéticos tipo 2 con nefropatía diabética, basado en resultados del estudio RENAAL
por: González F,Fernando, et al.
Publicado: (2009)